Skip to main content

Getty Images/iStockphoto

What are we looking for?

Canadian exchange-traded funds (ETFs) that offer a good mix of growth, valuation and low fees.

How did we do it?

Story continues below advertisement

Our friend, Craig McGee, senior consultant at CPMS Morningstar Canada, began by selecting ETFs that focus on the Canadian stock market. These include funds in the following categories: Canadian equity, Canadian dividend and income equity, and Canadian small/mid-cap equity.

Using Morningstar Direct's Scorecard tool, he ranked their holdings on the following six metrics:

  • average price-to-earnings ratio (for the trailing 12 months);
  • average price-to-book ratio;
  • average return on invested capital
  • average expected five-year annualized earnings growth rate
  • management fee
  • one-year total return (for the ETF itself)

His goal was to find baskets of stocks that, on average, offer growth at reasonable prices along with lower management fees and higher overall performance over the past year.

About Morningstar

Morningstar is a leading provider of independent investment research in North America, Europe, Australia and Asia. The company offers an extensive line of products and services for individuals, financial advisers and institutions.

Morningstar provides data on 422,000 investment offerings, including stocks, mutual funds and similar vehicles, along with real-time global market data on more than nine million equities, indexes, futures, options, commodities and precious metals, in addition to foreign exchange and treasury markets.

What we found

Story continues below advertisement

Only a few dozen ETFs exist in the categories that were surveyed, so take the results with a grain of salt. However, the funds that stand out on the half-dozen metrics we surveyed could offer decent choices for Canadian exposure as part of a complete portfolio.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter